Insys Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.07.17	Billionaires Bet Big On Canada's Newest $22 Billion Market (PR Newswire)
14.07.17	Sales of Legal Cannabis Products are Expected to Accelerate (PR Newswire)
13.07.17	Gainers & Losers Of July 12: CALA, TRVN, GEMP, ALDR, INSY... (RTTNews)
11.07.17	Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
11.07.17	Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
28.06.17	Legal Cannabis and CBD-Based Products Projected to Gain Popularity (PR Newswire)
15.06.17	Consumers Spending on Legal Cannabis Products Projected to Grow (PR Newswire)
15.05.17	DEADLINE UPDATE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Signet Jewelers Limited and Reminds Investors with Losses Over $100,000 to Contact the Firm (PR Newswire)
11.05.17	EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY (PR Newswire)
10.05.17	Marijuana Stocks Drive Corporate Value by Delivering Automation, Technology and Diverse Application (PR Newswire)
05.05.17	The Creation of Jobs in the Legal Cannabis Market (PR Newswire)
05.05.17	Research Reports Initiation on Biotech Stocks -- Trevena, Ocular Therapeutix, INSYS Therapeutics, and Pain Therapeutics (PR Newswire)
10.04.17	CBD Market Gains Attention (PR Newswire)
05.04.17	Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential (PR Newswire)
31.03.17	The Growth of Legal Cannabis Industry Sales (PR Newswire)
30.03.17	Pain-Reducing Combination Therapies Proving Successful Thanks to Innovative, Specialty Pharma Players (PR Newswire)
27.03.17	The Legal Cannabis Market Developments in 2017 (PR Newswire)
24.03.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY (PR Newswire)
21.03.17	Medicinal Cannabis Applications Target the Development of Enhanced Therapies and Treatments for Various Health Disorders (PR Newswire)
21.03.17	Medicinal Cannabis Applications Target the Development of Enhanced Therapies and Treatments for Various Health Disorders (PR Newswire)
20.03.17	Legal Cannabis Market Contributes to Tax Revenues (PR Newswire)
17.03.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline: May 16, 2017 (PR Newswire)
16.03.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INSYS Therapeutics, Inc. (INSY) (PR Newswire)
16.03.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INSYS Therapeutics, Inc - INSY (PR Newswire)
16.03.17	Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry (PR Newswire)
15.03.17	Legal Cannabis Sales Projected to Grow (PR Newswire)
13.03.17	FinancialBuzz.com: The Growth of Legal Cannabis Products (PR Newswire)
09.03.17	Research Reports Initiation on Biotech Stocks -- Alnylam Pharma, INSYS Therapeutics, Curis, and GenVec (PR Newswire)
06.03.17	Cannabinoid (CBD) Research and Development Remains Incredibly Strong in Spite of Federal Hesitation on Recreational Marijuana use (PR Newswire)
06.03.17	Cannabinoid (CBD) Research and Development Remains Incredibly Strong in Spite of Federal Hesitation on Recreational Marijuana use (PR Newswire)
28.02.17	FinancialBuzz.com: Legal Cannabis Market Projected to Become a Major Job Creation Force (PR Newswire)
17.02.17	Americans' Favorable Outlook on the Cannabis Market (PR Newswire)
16.02.17	Medicinal Cannabis Industry Turns Toward Biopharma Influence for Competitive Advantages in Product Development (PR Newswire)
16.02.17	Medicinal Cannabis Industry Turns Toward Biopharma Influence for Competitive Advantages in Product Development (PR Newswire)
16.02.17	Gainers & Losers Of The Day: ZSAN, EVOK, ARDX, EARS, NEOT... (RTTNews)
07.02.17	FinancialBuzz.com: Legal Cannabis Market Gains Popularity (PR Newswire)
03.02.17	Spending on Legal Cannabis Accelerates (PR Newswire)
26.01.17	Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, and AmpliPhi Biosciences (PR Newswire)
11.01.17	2017 Legal Cannabis Market Developments (PR Newswire)
05.01.17	The Cannabis Market Enters 2017 on a Strong Footing (PR Newswire)
08.12.16	Legal Cannabis Market is Gaining Attention (PR Newswire)
08.12.16	Technical Reports on Biotech Equities -- Aurinia Pharma, Threshold Pharma, Regeneron Pharma, and INSYS Therapeutics (PR Newswire)
30.11.16	Cannabis Industry Expects to Become the Next Biggest Market (PR Newswire)
29.11.16	Cannabis Companies Press on in Exploding Legal Marijuana Market (PR Newswire)
29.11.16	Cannabis Companies Press on in Exploding Legal Marijuana Market (PR Newswire)
23.11.16	Legal Cannabis Market Expects Growth (PR Newswire)
29.08.16	What's Smoking In The Legal Pot? (RTTNews)
25.08.16	HEB Gets Some Respite, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN (RTTNews)
24.08.16	Insys Therapeutics' Buprenorphine Sublingual Spray Trial Meets Primary Endpoint (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Insys Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten